Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Stories | |
Description | Explore stories about how Novartis innovation has impacted people |
Keywords | novartis, novartis stories |
WebSite | novartispharma.com |
Host IP | 45.60.13.232 |
Location | United States |
Site | Rank |
US$9,506,102
Last updated: 2023-05-08 17:09:44
novartispharma.com has Semrush global rank of 1,113,422. novartispharma.com has an estimated worth of US$ 9,506,102, based on its estimated Ads revenue. novartispharma.com receives approximately 1,096,858 unique visitors each day. Its web server is located in United States, with IP address 45.60.13.232. According to SiteAdvisor, novartispharma.com is safe to visit. |
Purchase/Sale Value | US$9,506,102 |
Daily Ads Revenue | US$8,775 |
Monthly Ads Revenue | US$263,246 |
Yearly Ads Revenue | US$3,158,951 |
Daily Unique Visitors | 73,124 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
novartispharma.com. | A | 86400 | IP: 45.60.13.232 |
novartispharma.com. | A | 86400 | IP: 45.60.11.232 |
novartispharma.com. | NS | 1800 | NS Record: a24-65.akam.net. |
novartispharma.com. | NS | 1800 | NS Record: a7-64.akam.net. |
novartispharma.com. | NS | 1800 | NS Record: a28-67.akam.net. |
novartispharma.com. | NS | 1800 | NS Record: dns4.novartis.com. |
novartispharma.com. | NS | 1800 | NS Record: dns2.novartis.com. |
novartispharma.com. | NS | 1800 | NS Record: dns3.novartis.com. |
novartispharma.com. | NS | 1800 | NS Record: a1-254.akam.net. |
novartispharma.com. | NS | 1800 | NS Record: dns1.novartis.com. |
novartispharma.com. | NS | 1800 | NS Record: a2-66.akam.net. |
novartispharma.com. | NS | 1800 | NS Record: a9-65.akam.net. |
novartispharma.com. | TXT | 86400 | TXT Record: QuoVadis=6b92f675-13b5-460f-90b0-76a449cdeffa |
novartispharma.com. | TXT | 86400 | TXT Record: 7cdd5904eb31493b86849e2bf3213f6d |
novartispharma.com. | TXT | 86400 | TXT Record: QuoVadis=8c5c8859-79dc-463e-a1cb-372bd00b49ba |
novartispharma.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=7sds8V_yxJs85tGBzTrGJBW_-FnpvcQ_6INfh5MCna |
Search Search section Global Digital ESG Media Center Careers Language & Country Selector for Desktop Global | en Choose Location International Americas Asia Pacific Europe Middle East & Africa Global | en Sandoz | en Novartis Foundation | en Argentina | es Brazil | pt Canada | en Canada | fr Central America | es Colombia | es Mexico | es United States | en Venezuela | es Australia | en Bangladesh | en Hong Kong S.A.R. | zh India | en Indonesia | en Japan | ja Korea | ko Mainland China | zh Malaysia | en Pakistan | en Philippines | en Singapore | en Taiwan | zh Austria | de Belgium | fr Belgium | nl Bulgaria | bg Czech Republic | cs Czech Republic | en Denmark | da Estonia | et Finland | fi France | fr Germany | de Greece | el Hungary | hu Ireland | en Italy | it Latvia | lv Lithuania | lt Netherlands | nl Norway | no Poland | pl Portugal | pt Romania | ro Russia | ru Serbia | sr Slovakia | sk Spain | es Sweden | sv Switzerland | de Switzerland | fr United Kingdom | en Egypt | en |
HTTP/1.1 301 Moved Permanently Date: Sat, 30 Oct 2021 10:06:16 GMT X-Frame-Options: SAMEORIGIN X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Content-Type: text/html; charset=iso-8859-1 Location: https://www.novartispharmaceuticals.com/ Vary: Accept-Encoding Set-Cookie: TS016b4d0c=01f27bbbb1d410ab999d5343490a4837a30f01c440264d06ba1701d951ce433da63fe6db5f8ba47ef4edc573f22d956c2fd98f3fc8; Path=/; Domain=.novartispharma.com; HTTPOnly Transfer-Encoding: chunked Set-Cookie: visid_incap_1358217=rnDppl1sT3+7tNo1xAJy6BYZfWEAAAAAQUIPAAAAAAC2bKqUm4wVbZ7l3Z6jtbHT; expires=Sat, 29 Oct 2022 12:05:30 GMT; HttpOnly; path=/; Domain=.novartispharma.com Set-Cookie: incap_ses_1102_1358217=n3pSSBb2+0q4eMFxmxdLDxgZfWEAAAAAXabTpgrPe9AWu1W3ZufAsg==; path=/; Domain=.novartispharma.com Set-Cookie: ___utmvmRZBuPvEwB=urBiYZHcbRZ; path=/; Max-Age=900 Set-Cookie: ___utmvaRZBuPvEwB=cVjhNcN; path=/; Max-Age=900 Set-Cookie: ___utmvbRZBuPvEwB=IZF XmrOpalt: Itf; path=/; Max-Age=900 X-CDN: Imperva X-Iinfo: 5-83382532-83382533 NNNN CT(23 -1 0) RT(1635588374078 0) q(0 0 1 1) r(20 20) U5 HTTP/2 301 date: Sat, 30 Oct 2021 10:06:17 GMT x-frame-options: SAMEORIGIN x-xss-protection: 1; mode=block x-content-type-options: nosniff content-type: text/html; charset=iso-8859-1 location: https://www.novartis.com/stories vary: Accept-Encoding set-cookie: TS01e82664=01f27bbbb1e045d7356e52fb7ae45abc34d47034e6d8bb4ae09fa35216b71f2893333ca8dbb3ddc0f017225c41d378e3509a8a672c; Path=/; Domain=.www.novartispharmaceuticals.com; Secure; HTTPOnly set-cookie: visid_incap_1358217=kjUtAbzWQfCEsUnd+S5eeBgZfWEAAAAAQUIPAAAAAADIufPJsnow0Ws3EVCXIDNe; expires=Sun, 30 Oct 2022 09:01:51 GMT; HttpOnly; path=/; Domain=.novartispharmaceuticals.com set-cookie: incap_ses_1003_1358217=EvZkUQZ5d1GVoNkBpF/rDRgZfWEAAAAAgpsQEz2JF7V+OlN0u99oBQ==; path=/; Domain=.novartispharmaceuticals.com x-cdn: Imperva x-iinfo: 1007-13411509-13411510 NNNN CT(95 193 0) RT(1635588376423 0) q(0 0 3 0) r(4 4) U5 HTTP/2 200 date: Sat, 30 Oct 2021 10:06:18 GMT content-type: text/html; charset=UTF-8 cache-control: public, max-age=18000 x-drupal-dynamic-cache: HIT x-ua-compatible: IE=edge content-language: en x-content-type-options: nosniff x-frame-options: SAMEORIGIN permissions-policy: interest-cohort=() expires: Sat, 30 Oct 2021 15:06:18 GMT last-modified: Sat, 30 Oct 2021 10:05:09 GMT vary: Cookie,Accept-Encoding x-generator: Drupal 9 (https://www.drupal.org) content-security-policy-report-only: script-src 'self' 'unsafe-inline' 'unsafe-eval' https://snap.licdn.com https://static.ads-twitter.com https://analytics.twitter.com https://connect.facebook.net https://cdn.cookielaw.org https://maxcdn.bootstrapcdn.com https://stackpath.bootstrapcdn.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://stackpath.bootstrapcdn.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://cdnsecakmi.kaltura.com:* https://cdnapisec.kaltura.com:* http://cdnapi.kaltura.com:* https://www.google-analytics.com:* https://cdn.jsdelivr.net:* https://script.crazyegg.com:* https://static.cloudflareinsights.com:*; style-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdn.cookielaw.org https://maxcdn.bootstrapcdn.com https://stackpath.bootstrapcdn.com https://www.youtube.com https://static.addtoany.com https://cdnjs.cloudflare.com https://stackpath.bootstrapcdn.com https://www.googletagmanager.com https://js-agent.newrelic.com https://geolocation.onetrust.com https://bam-cell.nr-data.net https://script.crazyegg.com https://static.cloudflareinsights.com; report-uri /report-csp-violation x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains x-request-id: v-dd497c0e-3968-11ec-bf34-23498fbd4f08 x-ah-environment: prod via: varnish x-cache: HIT x-cache-hits: 1 cf-cache-status: EXPIRED expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a63d4807ded2b7b-ORD |
Domain Name: NOVARTISPHARMA.COM Registry Domain ID: 11748121_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-01-22T15:50:02Z Creation Date: 1999-10-27T12:09:24Z Registry Expiry Date: 2022-10-27T12:09:24Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T20:39:17Z <<< |